Engineering Papers⌕ Search

Engineering topics

Johnstone, Carol

Publications and source records attributed to Johnstone, Carol.

At least 19 records

Secondary Beamline Lattice Design at the MeV Test Area (MTA)

The MTA is currently configured to produce a secondary pion beam from a tungsten target, which subsequently generates muons from decay in flight. In its present lattice configuration, the currently installed air core quadrupoles are strength-limited in their ability to deliver a high muon flux to the end user. Recently, seven strong iron-core quadrupole spares from the 400-MeV Linac were acquired. Based on these quadrupoles, a new lattice has been designed that maximizes both pion transport and muon capture the line based on significantly shorter magnetic lengths, strong magnetic gradients, and consequently an enhanced angular acceptance. For this project, we demonstrated that the ratio of muons to pions increased by over an order of magnitude (approximately 75 for lattice configurations were studied), successfully capturing a phase space area as large as 13.2 [mm] x 24 [mRad] in simulation.

Winter, Wesley↗

Low-energy muon and muonium beam source at Fermilab

We describe a high-efficiency source of muonium that can be transported as a beam in vacuum provides opportunities for fundamental muon and precision physics measurements such as sensitive searches for symmetry violation. Although PSI is currently the world leader, the intense 800-MeV PIP-II linac beam at Fermilab could provide world-class low-energy muon and muonium beams, with unparalleled intensity, driving the next generation of precision muon-based physics experiments at the intensity frontier. However, it is critical to initiate the prerequisite R&D now to prepare for the PIP-II era. A low-energy secondary muon line recently installed in an operating facility (the MeV Test Area, which utilizes the intense 400-MeV Fermilab Linac beam) could support the required R&D, and potentially compete for new physics in the immediate term, if approved. This beamline was developed for μ– and will need to be re-optimized for surface μ+ production and transport, making it also suitable for muon spin rotation physics––a unique research and industrial application for which no U.S. facility exists, and whose facilities are oversubscribed worldwide.

43 PARTICLE ACCELERATORS↗

A new center for heavy ion research

Progress in cancer therapy with ions heavier than protons, i.e., helium, carbon, oxygen and neon, requires research and development capability. Ion research activity, however, is limited from the absence of U.S. accelerator facilities offering ion beams for therapy – placing the U.S. significantly behind Europe and Asia. With dramatic advances in beam delivery and compact accelerators, the potential exists to create a facility that can play a leadership role in particle therapy and ion-based research. This paper announces summary details of a new center for ion therapy research under construction in Waco, TX, in collaboration with recognized accelerator entities both academic and industrial. The advanced accelerator technologies will produce beams for both clinical and research applications, offering a complete range of ions, intensities and energies required by the medical community, including the capability to perform ultra-high dose irradiation (FLASH) research. FLASH, a recent research initiative, which has the potential of reducing cancer treatment toxicities, is an important if not critical capability for a competitive research center – requiring beam intensities well beyond those provided by current medical accelerators. Building a state-of-the-art cancer research center within a comprehensive facility will provide the resources to promote ion therapy in the U.S, including, preclinical/clinical trials and protocols between modalities, and also support broad ion R&D.

43 PARTICLE ACCELERATORS↗

Transformative Technology for FLASH Radiation Therapy

The general concept of radiation therapy used in conventional cancer treatment is to increase the therapeutic index by creating a physical dose differential between tumors and normal tissues through precision dose targeting, image guidance, and radiation beams that deliver a radiation dose with high conformality, e.g., protons and ions. However, the treatment and cure are still limited by normal tissue radiation toxicity, with the corresponding side effects. A fundamentally different paradigm for increasing the therapeutic index of radiation therapy has emerged recently, supported by preclinical research, and based on the FLASH radiation effect. FLASH radiation therapy (FLASH-RT) is an ultra-high-dose-rate delivery of a therapeutic radiation dose within a fraction of a second. Experimental studies have shown that normal tissues seem to be universally spared at these high dose rates, whereas tumors are not. While dose delivery conditions to achieve a FLASH effect are not yet fully characterized, it is currently estimated that doses delivered in less than 200 ms produce normal-tissue-sparing effects, yet effectively kill tumor cells. Despite a great opportunity, there are many technical challenges for the accelerator community to create the required dose rates with novel compact accelerators to ensure the safe delivery of FLASH radiation beams.

43 PARTICLE ACCELERATORS↗

Transformative Technology for FLASH Radiation Therapy: A Snowmass 2021 White Paper

Conventional cancer therapies include surgery, radiation therapy, chemotherapy, and, more recently, immunotherapy. These modalities are often combined to improve the therapeutic index. The general concept of radiation therapy is to increase the therapeutic index by creating a physical dose differential between tumors and normal tissues through precision dose targeting, image guidance, and high radiation beams that deliver radiation dose with high conformality, e.g., protons and ions. However, treatment and cure are still limited by normal tissue radiation toxicity, with many patients experiencing acute and long-term side effects. Recently, however, a fundamentally different paradigm for increasing the therapeutic index of radiation therapy has emerged, supported by preclinical research, and based on the FLASH radiation effect. FLASH radiation therapy (FLASH-RT) is an ultra-high dose-rate delivery of a therapeutic radiation dose within a fraction of a second. Experimental studies have shown that normal tissues seem to be universally spared at these high dose rates, whereas tumors are not. The dose delivery conditions are not yet fully characterized. Still, it is currently estimated that large doses of 10 Gy or more delivered in 200 ms or less produce normal tissue sparing effects yet effectively kill tumor cells. There is a great opportunity, but also many technical challenges, for the accelerator community to create the required dose rates with novel and compact accelerators to ensure the safe delivery of FLASH radiation beams.

43 PARTICLE ACCELERATORS↗

FNAL PIP-II Accumulator Ring

The FNAL accelerator complex is poised to reach MW neutrino beams on target for the exploration of the dark sector physics and rare physics program spaces. Future operations of the complex will include CW linac operations at beam intensities that have not been seen before \cite{PIP2,RCS_LOI}. The ambitious beam program relies on multi-turn H$^{-}$ injection into the FNAL Booster and then extracted into delivery rings or the Booster Neutrino Beam (BNB) 8 GeV HEP program. A new rapid-cycling synchrotron (RCS) will be required to reach the LBNF goal of 2.4 MW because of intense space-charge limitations. There are many accelerator engineering challenges that are already known and many that will be discovered. This proposal calls for an intermediate step that will both facilitate the operation of Booster in the PIP-II era and gain operational experience associated with high power injection rings. This step includes the design, construction and installation of a 0.8 GeV accumulator ring (upgradeable to 1+ GeV) to be located in the PIP-II Booster Transfer Line (BTL). The PIP-II accumulator ring (PAR) may be primarily designed around permanent magnets or use standard iron core magnet technology with an aperture selected to accommodate the desired high intensity protons at 0.8 GeV.

43 PARTICLE ACCELERATORS↗

Electromagnetic and Engineering Design of a High-Current 15-MeV/u Cyclotron

The capability to produce high current, low loss, and extracted external ion beams presents an enabling technology for nuclear security, isotope production, and medical applications. We report on a novel, continuous-wave cyclotron for accelerating light ions with a charge-to-mass ratio of 1/2, which is designed for 1 mA maximum and 15 MeV/u energy. This article details the conceptual electromagnetic (EM) and engineering design including the 1.1 T sector magnets and 45 MHz, 200 kV radio frequency (RF) cavities. We discuss the cyclotron beam parameters with respect to potential commercial and industrial applications. The general concept and the accelerator’s layout are followed by a detailed EM design of magnets and RF cavities. Finally, practical engineering design considerations will be provided.

07 ISOTOPE AND RADIATION SOURCES↗

High-Current Light-Ion Cyclotron for Applications in Nuclear Security and Radioisotope Production

In this article, we propose the conceptual design, with supporting beam dynamics results, of a normal conducting, separated-sector cyclotron with a strong-focusing field gradient designed to accelerate light ions with a charge-to-mass ratio of 1/2 up to 15–20 MeV/u. The design can support a host of applications for therapy, radiobiology, material science, and instrumentation development. The light-ion species, which can include a mixed ion beam, can be dynamically chosen to provide a range of characteristic signals appropriate for specific material identification such as special nuclear materials. A conservative baseline concept is presented which has been optimized for radioisotope production of alpha emitters and theranostic radiopharmaceuticals. The modular design is also demonstrated to be scalable in gross physical parameters by a factor of 2–3, thereby reducing the size, weight, and power requirements (SWaP) and enabling near-term security applications.

07 ISOTOPE AND RADIATION SOURCES↗

Compact, Achromatic Non-scaling FFAG Accelerator for HEP, Commercial and Medical Applications (CRADA FRA-2008-0005 Final Report)

Proton and light-ion accelerators have many research and medical applications, but the current state of technology in accelerators severely limits their widespread use: (1) synchrotrons have an intrinsic low duty cycle and become quite large for light ions; and (2) cyclotrons do not have energy variability and require complex superconducting magnets for high energy. A new concept in non-scaling Fixed-Field Alternating-Gradient (FFAGs) has been invented that incorporates both the energy variability of the synchrotron and the high duty cycle of the cyclotron. The concept uses normal-conducting, combined-function magnets that apply only constant (dipole) and linear-gradient (quadrupole) fields to stabilize the accelerator. This project will develop an optimized design for a new non-scaling and cost-effective innovation in FFAG accelerators. The accelerator design will have optics that can stably accelerate protons to 250 MeV (or higher) and carbon ions to =200 MeV, an energy considered ideal for radiation therapy. Phase I will optimize, fully simulate, and demonstrate the feasibility of this accelerator. Commercial Applications and other Benefits as described by the awardee: The fixed-field acceleration concept should eliminate some of the most pronounced technical difficulties, expense, maintenance, and required expertise faced in conventional proton and light-ion accelerators. In addition to the application for high energy physics, these accelerators should have application in cancer treatment, radiopharmaceuticals, and medical isotope production, and materials science.

43 PARTICLE ACCELERATORS↗

A 15-Mev/nucleon Iso-Cyclotron for Security and Radioisotope Production

Cargo inspection systems exploit the broad bremsstrahlung spectrum from a 6-10 MeV, low-duty cycle electron accelerator which in the presence of significant backgrounds presents challenges in image and material identification. An alternative approach is to use ions which can excite nuclear states either directly, or through generation of secondary high-energy signature gammas produced from nuclear interactions in a target. RadiaBeam is designing a compact sector isocyclotron 1.25 m in radius, with high-gradient cavities to accelerate multi-ion species up to 15-20 MeV/u with large turn-to turn, centimeter-level separation for low-loss extraction without lossy foil stripping. A strong-focusing radial field profile will be optimized in a separated-sector format for control over machine tune simultaneous with isochronous orbist requirements for high-current (~0.5 milliamp) operation. Innovation in injection will be introduced to replace the high-loss central region. Non-security applications of the cyclotron include medical isotope production, ion radiobiology, as well as material science research and ion instrumentation development.

43 PARTICLE ACCELERATORS↗

A Review of Nonscaling CW FFAs for Proton and Ion Therapy Applications

Significant progress on compact, variable-energy versions of non-scaling fixed field accelerators with alternating strong-focusing gradients (nsFFA) has been made and adapted to proton and ion therapy. Not only has isochronous (CW) capability been demonstrated in a realizable design, an isochronous racetrack format has evolved which supports lengthy, synchrotron-like straight sections. Long straight insertions promote low-loss injection and extraction systems and further facilitate extracting lower-energy orbits using a bipolar bump-magnet system. To efficiently extract variable energy using this method, the accelerator complex requires separated accelerator stages, each stage with limited but therapeutically optimized energy ranges targeting specific cancer types and penetration depths. Different energy stages further support multiple treatment rooms increasing patient throughput and reducing treatment cost. The staged system proposed here also realizes cost savings in gantries by tailoring delivery to different therapeutic energies and beam requirements, promoting the requirement for only one high-energy gantry in the facility. The proposed facility consists of 3 stages, a 30 MeV injector, a 30 - 90 MeV/nucleon FFA for shallow cancers, and 90 - 250/330 MeV/nucleon stage for deep tumors, pelvis for example. The higher energy of the final stage, 330 MeV/nucleon is preferred to support Proton Computed Tomography. Isochronous FFA stages can be designed to accelerate either protons or ions with charge to mass of 1/2.

43 PARTICLE ACCELERATORS↗

Radiation Shielding Calculations for E1039 Seaquest Experiment

The E1039 Seaquest experiment is designed to study results of interactions of the 120 GeV proton beam, delivered from Main Injector, with transversely polarized hydrogen target in the form of liquid ammonia (NH3). The E1039 experiment is re-using the Neutrino-Muon beamline, spectrometer magnet (FMAG), KMAG, and other hardware from its predecessor—the E906 experiment. Only the central 2 Tesla magnetic field was modeled in the FMAG magnet which also serves also as a beam absorber. Various updates were performed to the beamline and shielding around the magnet compared to E906 including relocation of the target 3 meters upstream of the front face of FMAG. Further, several updates were performed on the MARS15 model developed previously [1-2] in order to better describe important surrounding areas, in particular the counting room. Several optimization iterations of the shielding design were done and only the final configuration is discussed in this document. The model includes realistically stacked concrete shielding blocks along with airgaps required for piping, ductwork and detectors. The main features of the shielding update can be summarized as follows: (i) additional concrete shielding was added above the magnet to degrade the energy of neutrons to thermal levels; (ii) a new target alcove with the target cryostat inside. These updates are intended to provide increased protection for both normal operation and accident conditions upstream of the target. The Figures 1 thru 3 below describe the MARS15 model in detail as well as an excerpt of the 3D CAD model design which was used to build the MARS15 model.

43 PARTICLE ACCELERATORS↗

Prospects for a Muon Spin Resonance Facility in the Fermilab MuCool Test Area

This paper investigates the feasibility of re-purposing the MuCool Test Area (MTA) beamline and experimental hall to support a Muon Spin Resonance (MuSR) facility, which would make it the only such facility in the US. This report reviews the basic muon production concepts studied and operationally implemented at TRIUMF, PSI, and RAL and their application in the context of the MTA facility. Two scenarios were determined feasible. One, an initial minimal-shielding and capital-cost investment stage with a single secondary muon beamline that utilizes an existing high- intensity beam absorber and, another, upgraded stage, that implements an optimized production target pile, a proximate high-intensity absorber, and optimized secondary muon lines. A unique approach is proposed which chops or strips a macropulse of H$^-$ beam into a micropulse substructure – a muon creation timing scheme – which allows Muon Spin Resonance experiments in a linac environment. With this timing scheme, and attention to target design and secondary beam collection, the MTA can host enabling and competitive Muon Spin Resonance experiments.

43 PARTICLE ACCELERATORS↗

HEATHER - HElium Ion Accelerator for RadioTHERapy

A non-scaling fixed field alternating gradient (nsFFAG) accelerator is being designed for helium ion therapy. This facility will consist of 2 superconducting rings, treating with helium ions (He²⁺ ) and image with hydrogen ions (H + 2 ). Currently only carbon ions are used to treat cancer, yet there is an increasing interest in the use of lighter ions for therapy. Lighter ions have reduced dose tail beyond the tumour compared to carbon, caused by low Z secondary particles produced via inelastic nuclear reactions. An FFAG approach for helium therapy has never been previously considered. Having demonstrated isochronous acceleration from 0.5 MeV to 900 MeV, we now demonstrate the survival of a realistic beam across both stages.

43 PARTICLE ACCELERATORS↗

Thin Internal Target Studies in a Compact FFAG

The production of radioisotopes using a thin internal target and recycled beam within a compact FFAG design has been studied. Radioisotopes have a wide range of uses in medicine, and recent disruption to the supply chain has seen a renewed effort to find alternative isotopes and production methods. The FFAG design features separate sector magnets with non-scaling, non-linear field gradients which are optimized with magnet geometry to achieve isochronisity at the level of 0.3%, sufficient for Continuous Wave (CW) operation. Simulations have demonstrated that beam currents of up to 10mA can comfortably be achieved with this design. To further improve production efficiency a thin internal target, where the beam passes through the target and is recirculated, may be used. This setup ensures that production takes place within a narrow energy range, potentially increasing production rates and reducing impurities.

43 PARTICLE ACCELERATORS↗

Performance Analysis for the New g-2 Experiment at Fermilab

The new g-2 experiment at Fermilab aims to measure the muon anomalous magnetic moment to a precision of ±0.14 ppm - a fourfold improvement over the 0.54 ppm precision obtained in the g-2 BNL E821experiment. Achieving this goal requires the delivery of highly polarized 3.094 GeV/c muons with a narrow ±0.5% Δp/p acceptance to the g-2 storage ring. In this study, we describe a muon capture and transport scheme that should meet this requirement. First, we present the conceptual design of our proposed scheme wherein we describe its basic features. Then, we detail its performance numerically by simulating the pion production in the (g-2) production target, the muon collection by the downstream beamline optics as well as the beam polarization and spin-momentum correlation up to the storage ring. The sensitivity in performance of our proposed channel against key parameters such as magnet apertures and magnet positioning errors is analyzed

43 PARTICLE ACCELERATORS↗